Overview

Staccato Zaleplon Single Dose Pharmacokinetics

Status:
Completed

Trial end date:
2008-03-01

Target enrollment:

Participant gender:

Summary

The purpose of the study is to determine the safety, tolerability and pharmacokinetics of zaleplon delivered by the Staccato thermal aerosol system in healthy volunteers

Phase:

Phase 1

Details

Lead Sponsor:

Alexza Pharmaceuticals, Inc.

Treatments:

Zaleplon